This paper is in the following e-collection/theme issue:

Non-randomized Protocols and Methods (ehealth) (542) mHealth for Wellness, Behavior Change and Prevention (2754) Mobile Apps for Cardiology (127) Cardiovascular Disease Prevention (115)

Published on in Vol 8, No 1 (2019): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/9017, first published .
American Heart Association’s Cholesterol CarePlan as a Smartphone-Delivered Web App for Patients Prescribed Cholesterol-Lowering Medication: Protocol for an Observational Feasibility Study

American Heart Association’s Cholesterol CarePlan as a Smartphone-Delivered Web App for Patients Prescribed Cholesterol-Lowering Medication: Protocol for an Observational Feasibility Study

American Heart Association’s Cholesterol CarePlan as a Smartphone-Delivered Web App for Patients Prescribed Cholesterol-Lowering Medication: Protocol for an Observational Feasibility Study

Authors of this article:

Maria Woringer1 Author Orcid Image ;   Kanika I Dharmayat1 Author Orcid Image ;   Geva Greenfield1 Author Orcid Image ;   Alex Bottle1 Author Orcid Image ;   Kausik K. Ray1 Author Orcid Image
Article Authors Cited by (3) Tweetations (7) Metrics

Journals

  1. Agher D, Sedki K, Tsopra R, Despres S, Jaulent M. Influence of Connected Health Interventions for Adherence to Cardiovascular Disease Prevention: A Scoping Review. Applied Clinical Informatics 2020;11(04):544 View
  2. Makhmudova U, Wolf M, Willfeld K, Beier L, Weingärtner O. Different Perspectives of Patients and Physicians on LDL-C Target Achievement in the Treatment of Hypercholesterolemia: Results on Secondary Prevention from the German PROCYON Survey. Advances in Therapy 2023;40(2):460 View
  3. Makhmudova U, Wolf M, Willfeld K, Beier L, Weingärtner O. Primär- und Sekundärprävention bei Hypercholesterinämie – versorgungsrelevante Unterschiede in der PROCYON-Studie. DMW - Deutsche Medizinische Wochenschrift 2023;148(19):e101 View